Microsoft's 2029 quantum supercomputer ambitions may have hit a roadblock, as critics claim the company's 2025 quantum ...

North Korea-linked ScarCruft uses fake Microsoft Account alerts and ZIP files to deliver NarwhalRAT, a Python RAT built for ...

Microsoft warned customers on Tuesday that they may have issues installing the latest monthly updates on some Windows devices that were upgraded to Windows 11 24H2 or 25H2. On affected systems, users ...

Microsoft is embracing Linux-like command line utilities and integrating its Linux subsystem even further into Windows. Microsoft is embracing Linux-like command line utilities and integrating its ...

Microsoft’s Build 2026 Windows updates add developer setup tools, local AI models, Linux workflows, and agent security controls. Windows is getting a major developer-focused upgrade as Microsoft ...

Microsoft has released Windows 11 KB5095093, bringing Windows Ready Print improvements, WSL fixes, AI enhancements, and ...

A vulnerability chain dubbed AutoJack in Microsoft's AutoGen Studio interface for prototyping AI agents could let attackers ...

Build will include a Copilot super app, a new reasoning AI model, and lots of Windows improvements. Build will include a Copilot super app, a new reasoning AI model, and lots of Windows improvements.

Microsoft's developer-focused Build conference is usually heavy on technical details, but it's still the best way to get a sneak peek into what the company has in store for your Windows PC. I'll be on ...

Microsoft officially confirms no Windows 12 announcement at Build 2026, despite widespread social media speculation about a new operating system. PCWorld reports that Microsoft is instead focusing on ...

Microsoft’s Build developer conference kicked off today, and as with almost everything the company has done in the last few years, Microsoft’s opening keynote focused overwhelmingly on AI and other ...

CHARLOTTE — The investigational oral Bruton tyrosine kinase inhibitor (BTKi) fenebrutinib significantly outperformed teriflunomide on relapse and MRI outcomes, marking the first potential win ...